title: Concerns about using Zn supplementation in Down's syndrome (DS) children.
authors.forename: I
authors.initials: I
authors.lastname: Bucci
authors.forename: G
authors.initials: G
authors.lastname: Napolitano
authors.forename: C
authors.initials: C
authors.lastname: Giuliani
authors.forename: S
authors.initials: S
authors.lastname: Lio
authors.forename: A
authors.initials: A
authors.lastname: Minnucci
authors.forename: F
authors.initials: F
authors.lastname: Monaco
authors.forename: F
authors.initials: F
authors.lastname: Di Giacomo
authors.forename: G
authors.initials: G
authors.lastname: Calabrese
authors.forename: G
authors.initials: G
authors.lastname: Palka
authors.forename: G
authors.initials: G
authors.lastname: Sabatino
mesh_terms: D000544:Alzheimer Disease / Q000209:etiology / Q000378:metabolism; D016229:Amyloid beta-Peptides / Q000378:metabolism; D002648:Child; D019587:Dietary Supplements; D004314:Down Syndrome / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D015032:Zinc / Q000008:administration & dosage*
chemical_list: D016229:Amyloid beta-Peptides; D015032:Zinc